Mualliflar

  • Giyosova N.O.

##semicolon##

Adiponectin; Nephropathy; Bronchial Asthma; Obesity; Biomarkers; Renal Function.

##submission.citations##

Aging-US. Adiponectin in renal fibrosis review. 2020.

Ha KH, et al. Urinary adiponectin and progression of diabetic nephropathy. Diabetes & Metabolism Journal. 2015;39(2):137‑145.

Heidari M. Adiponectin in chronic kidney disease: pathophysiology and clinical associations. 2015.

Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel adipose‑specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis, Vascular Biology. 2000;20(6):1595–1599.

Kadowaki T, Yamauchi T. Adiponectin and its receptors in insulin resistance, diabetes, and metabolic syndrome. J Clin Invest. 2005.

Karimi F, et al. Early Detection of Diabetic Nephropathy Based on Urinary Biomarkers: Systematic Review. 2024.

Mendes FA, et al. Adipokines and lung function decline in asthma: a systematic review. Allergy, Asthma & Immunol Res. 2018.

Song SH, et al. High serum adiponectin as a biomarker of renal dysfunction: prospective cohort analysis. Scientific Reports. 2020; 10:62465.

Sood A, et al. Adiponectin and asthma in adults: epidemiologic evidence. Resp Med. 2014.

Zoccali C, Mallamaci F, et al. Adiponectin and mortality in patients with kidney disease. Nephrology Journal. 2011.